Eli Lilly to expand R&D investment

Published: 2007-09-06 06:58:00

Updated: 2007-09-06 06:58:00

Eli Lilly and Co. will unveil its plans to increase investment for cancer research in Korea, aiming to take advantage of the country's talented medical scientists and need for new drugs, according to Lilly Korea.

Lilly's executives visited Seoul to attend the World Conference on Lung Cancer, w...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK